Ethical and legal perspective of implantable cardioverter defibrillator deactivation or implantable cardioverter defibrillator generator replacement in the elderly

Current Opinion in Cardiology

Volumn 28, Issue 1, 2013, Pages 43-49

  Wright, Gary A ^a   Klein, George J ^a   Gula, Lorne J ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

elderly; ethics; ICD deactivation; legal

Indexed keywords

ANTIARRHYTHMIC AGENT;

AGED; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DEVICE REMOVAL; DOCTOR PATIENT RELATION; GENERATOR; GERIATRIC PATIENT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR DEACTIVATION; INFORMED CONSENT; MEDICAL ETHICS; MEDICAL SOCIETY; MEDICOLEGAL ASPECT; MULTICENTER STUDY (TOPIC); PATIENT DECISION MAKING; PATIENT EDUCATION; PATIENT RIGHT; PHYSICIAN; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SECONDARY PREVENTION; SUDDEN DEATH; SURVIVAL; TACHYCARDIA; TERMINAL CARE; TREATMENT PLANNING; TREATMENT REFUSAL; VOLUNTARY EUTHANASIA;

ADVANCE CARE PLANNING; ADVANCED CARDIAC LIFE SUPPORT; AGE FACTORS; AGED; AGED, 80 AND OVER; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HEALTH SERVICES FOR THE AGED; HUMANS; TERMINAL CARE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84871628804     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32835b0b3b     Document Type: Review

References (41)

1. Goldstein NE, Lampert R, Bradley E, et al. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med 2004; 141:835-838. (Pubitemid 39601176)
2. Mueller PS, Jenkins SM, Bramstedt KA, Hayes DL. Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes. Pacing Clin Electrophysiol 2008; 31:560-568. (Pubitemid 351595284)
3. Schron EB, Exner DV, YaoQ, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002; 105:589-594. (Pubitemid 34123433)
4. Hammill SC, Kremers MS, Kadish AH, et al. Review of the ICD Registry's Third Year, expansion toinclude lead data and pediatric ICD procedures, and role for measuring performance. Heart Rhythm 2009; 6:1397-1401.
5. John Camm A, Nisam S. European utilization of the implantable defibrillator: has 10 years changed the 'enigma'? Europace 2010; 12:1063-1069.
6. Camm AJ, Nisam S. The utilization of the implantable defibrillator-a European enigma. Eur Heart J 2000; 21:1998-2004. (Pubitemid 32006213)
7. Healey JS, Hallstrom AP, Kuck KH, et al. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur Heart J 2007; 28:1746-1749. (Pubitemid 47227082)
8. Myerburg RJ. Implantable cardioverter-defibrillators after myocardial infarction. N Engl J Med 2008; 359:2245-2253.
9. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverterdefibrillator for congestive heart failure. N Engl J Med 2005; 352:225-237. (Pubitemid 40110811)
10. Huang DT, Sesselberg HW, McNitt S, et al. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy. J Cardiovasc Electrophysiol 2007; 18:833-838. (Pubitemid 47093069)
11. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350:2140-2150.
12. Koplan BA, Epstein LM, Albert CM, Stevenson WG. Survival in octogenarians receiving implantable defibrillators. Am Heart J 2006; 152:714-719. (Pubitemid 44396897)
13. Lee DS, Tu JV, Austin PC, et al. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol 2007; 49:2408-2415. (Pubitemid 46962260)
14. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346:877-883. (Pubitemid 34984635)
15. Krahn AD, Lee DS, Birnie D, et al. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the OntarioICD Database. Circ Arrhythm Electrophysiol 2011; 4:136-142.
16. Gould PA, Gula LJ, Champagne J, et al. Outcome of advisory implantable cardioverter-defibrillator replacement: one-year follow-up. Heart Rhythm 2008; 5:1675-1681.
17. Poole JE, Gleva MJ, Mela T, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation 2010; 122:1553-1561.
18. GermanoJJ, Reynolds M, Essebag V, Josephson ME. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol 2006; 97:1255-1261.
19. Tzeis S, Andrikopoulos G, Kolb C, Vardas PE. Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks. Europace 2008; 10:1256-1265.
20. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 2005; 353:1471-1480. (Pubitemid 41400921)
21. Hauptman PJ, Swindle J, Hussain Z, et al. Physician attitudes toward endstage heart failure: a national survey. Am J Med 2008; 121:127-135. (Pubitemid 351199454)
22. Epstein AE, DiMarcoJP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee toRevise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117:e350-e408.
23. Padeletti L, Arnar DO, Boncinelli L, et al. EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace 2010; 12:1480-1489.
24. Wilkoff BL, AuricchioA, Brugada J, et al. HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association. Europace 2008; 10:707-725.
25. Francis GS, Greenberg BH, Hsu DT, et al. ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on management of patients with advanced heart failure and cardiac transplant: a report of the ACCF/AHA/ ACP Task Force on Clinical Competence and Training. Circulation 2010; 122:644-672.
26. Lee DS, Austin PC, Rouleau JL, et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003; 290:2581-2587. (Pubitemid 37443288)
27. Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J 2007; 154:260-266. (Pubitemid 47079017)
28. Goldenberg I, Vyas AK, Hall WJ, et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008; 51:288-296.
29. Kay GN, Bittner GT. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated?: an ethical distinction. Circulation 2009; 2:336-339.
30. PellegrinoED. Decisions towithdraw life-sustaining treatment: a moral algorithm. JAMA 2000; 283:1065-1067. (Pubitemid 30112225)
31. Quill TE, Barold SS, Sussman BL. Discontinuing an implantable cardioverter defibrillator as a life-sustaining treatment. Am J Cardiol 1994; 74:205-207.
32. Rhymes JA, McCullough LB, Luchi RJ, et al. Withdrawing very low-burden interventions in chronically ill patients. JAMA 2000; 283:1061-1063. (Pubitemid 30112224)
33. Wu EB. The ethics of implantable devices. J Med Ethics 2007; 33:532-533.
34. Wiegand DL, Kalowes PG. Withdrawal of cardiac medications and devices. AACN Adv Crit Care 2007; 18:415-425.
35. Lampert R, Hayes DL, Annas GJ, et al. HRS Expert Consensus Statement on the management of cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm 2010; 7:1008-1026.
36. Goldstein NE, Mehta D, Siddiqui S, et al. 'That's like an act of suicide' patients' attitudes toward deactivation of implantable defibrillators. J Gen Intern Med 2008; 23 (Suppl. 1):7-12. (Pubitemid 350295388)
37. Marinskis G, van Erven L. Deactivation of implanted cardioverter- defibrillators at the end of life: results of the EHRA survey. Europace 2010; 12:1176-1177.
38. Goldstein N, Bradley E, Zeidman J, et al. Barriers toconversations about deactivation of implantable defibrillators in seriously ill patients: results of a nationwide survey comparing cardiology specialists toprimary care physicians. J Am Coll Cardiol 2009; 54:371-373.
39. Goldstein NE, Mehta D, Teitelbaum E, et al. 'It's like crossing a bridge' complexities preventing physicians from discussing deactivation of implantable defibrillators at the end of life. J Gen Intern Med 2008; 23 (Suppl. 1): 2-6. (Pubitemid 350295386)
40. Kapa S, Mueller PS, Hayes DL, Asirvatham SJ. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients. MayoClin Proc 2010; 85:981-990.
41. Clark AM, Jaarsma T, Strachan P, et al. Effective communication and ethical consent in decisions related toICDs. Nat Rev Cardiol 2011; 8:694-705.